KAPOSI SARCOMA

Clinical trials for KAPOSI SARCOMA explained in plain language.

Never miss a new study

Get alerted when new KAPOSI SARCOMA trials appear

Sign up with your email to follow new studies for KAPOSI SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 2 Not yet finished but already full! 2 Terminated 1

Immunotherapy duo tackles HIV-Linked tumors

Disease control Terminated

This early-stage study tested two immunotherapy drugs, ipilimumab and nivolumab, together in people with HIV who also had certain advanced cancers (like lymphoma or solid tumors). The main goal was to find the safest dose and understand side effects. The study was stopped early, …

Matched conditions: KAPOSI SARCOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 15, 2026 11:55 UTC

KAPOSI SARCOMA

Get alerted when new KAPOSI SARCOMA trials appear

Immunotherapy duo tackles HIV-Linked tumors